Financial Justification for Interventional Pulmonology Programs
| Autor: | Jennifer Bautista, Amit K. Mahajan, Erin Hodson, Susan Carroll, Sandeep J. Khandhar, Erik Folch, Steve Narang |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Pulmonary and Respiratory Medicine
Finance Contribution margin business.industry Total revenue Critical Care and Intensive Care Medicine Adjusted gross income Terminology 03 medical and health sciences Indirect costs 0302 clinical medicine 030228 respiratory system Revenue Current Procedural Terminology Medicine 030212 general & internal medicine Cardiology and Cardiovascular Medicine business Pulmonologists |
| Zdroj: | Chest. 158:1115-1121 |
| ISSN: | 0012-3692 |
| DOI: | 10.1016/j.chest.2020.02.026 |
| Popis: | Interventional pulmonology programs provide clinical benefit to patients and are financially sustainable. To appreciate and illustrate the economic value of interventional pulmonology programs to hospital systems, physicians must have an understanding of basic health-care finance. Total revenue, adjusted gross revenue, contribution margin, variable direct costs, and indirect costs are terms that are essential for understanding the finances of bronchoscopy. Command of such vocabulary and its application is crucial for interventional pulmonologists to successfully establish financially sustainable bronchoscopy programs. Two significant features of an economically sustainable bronchoscopy program are high procedural volume and low direct cost per case. Interventional pulmonology programs are valuable to the patients being served and hospitals as a whole. Consideration of the various factors needed to maintain financial sustainability is essential to improve the quality of care for patients because the cost of care remains a critical driver in defining value. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|